Benitec Biopharma SG&A Expense (Annual) Trends

Benitec Biopharma Inc (BNTC)

9.48 -0.33 (-3.36%) USD | NASDAQ | Oct 04, 16:00

9.40 -0.08 (-0.84%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2013. Upgrade now.

Date	Value
June 30, 2024	6.989M
June 30, 2023	6.382M
June 30, 2022	6.646M
June 30, 2021	6.512M
June 30, 2020	5.567M
June 30, 2019	4.614M

Date	Value
June 30, 2018	6.41M
June 30, 2017	6.990M
June 30, 2016	8.746M
June 30, 2015	6.170M
June 30, 2014	7.666M
June 30, 2013	4.385M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

5.567M

Minimum

2020

6.989M

Maximum

2024

6.419M

Average

6.512M

Median

2021

SG&A Expense (Annual) Benchmarks